This inventor holds 3 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2005-2011.
Company Filing History:
Years Active: 2005-2011
Title: Liora Strichman-Almashanu: Innovator in Genomic Research
Introduction
Liora Strichman-Almashanu is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of genomic research, particularly in the study of methylated CpG islands and gene imprinting. With a total of 3 patents, her work has implications for understanding genetic diseases and developmental biology.
Latest Patents
One of her latest patents is titled "Methods of isolating methylated CpG islands." This patent provides a method for isolating methylated CpG islands by identifying an imprinted gene adjacent to the methylated region. It also involves identifying diseases that are preferentially transmitted by one parent and genetically linked to the imprinted gene, thereby indicating its potential role in disease transmission. Another significant patent is "Gene imprinting and methylated CpG islands." This work explores genomic imprinting, which is a parent-of-origin-dependent gene silencing mechanism. It discusses the establishment of a model system for genomic imprinting using mouse embryonic germ cell lines and highlights the complexities of allele-specific gene expression and silencing.
Career Highlights
Liora Strichman-Almashanu is affiliated with Johns Hopkins University, where she conducts her research. Her innovative approaches have led to the generation of a library containing most methylated CpG islands, revealing distinct subtypes of these islands. This research contributes to a deeper understanding of the methylome throughout the genome.
Collaborations
She has collaborated with notable researchers such as Andrew P. Feinberg and Shan Jiang, further enhancing the impact of her work in the scientific community.
Conclusion
Liora Strichman-Almashanu's contributions to genomic research through her patents and collaborations underscore her role as a leading inventor in the field. Her work continues to advance our understanding of genetic mechanisms and their implications for human health.